SNN Smith & Nephew
- 24.140
- +0.010+0.04%
- 24.480
- +0.340+1.41%
Smith & Nephew News
Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew Plc
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We adjust our target price by $3 to $27,
Smith & Nephew Logs Higher Q1 Revenue; FY24 Guidance Affirmed
Smith & Nephew (SN.L) on Wednesday reported a year-over-year increase to its revenue in the first quarter. The medical technology group's revenue for the three months ended March 30 was nearly $1.39 b
Smith & Nephew Confident in Outlook in All Three of Business Units
Smith & Nephew Confident in Outlook in All Three of Business Units
Smith & Nephew Sees 2024 Underlying Rev Growth of 5.0%-6.0%
Smith & Nephew Sees 2024 Underlying Rev Growth of 5.0%-6.0%
Earnings Flash (SN.L) SMITH & NEPHEW Posts Q1 Revenue $1.39B
02:08 AM EDT, 05/01/2024 (MT Newswires) -- Earnings Flash (SN.L) SMITH & NEPHEW Posts Q1 Revenue $1.39B
Smith & Nephew 1Q Orthopaedics Rev Up 4.4% on Underlying Basis
Smith & Nephew 1Q Orthopaedics Rev Up 4.4% on Underlying Basis
Smith & Nephew Saw Continued Weakness in US Hip and Knee Implants
Smith & Nephew Saw Continued Weakness in US Hip and Knee Implants
Smith & Nephew 1Q Rev $1.39B
Smith & Nephew 1Q Rev $1.39B
Smith & Nephew Plc Backs 2024 View
Smith & Nephew Plc Backs 2024 View
Europe Scar Management Market Analysis Report 2024: A $350+ Million Market by 2030 With Advancis Medical, Bayer, B. Braun, Molnlycke Health Care, Smith & Nephew, and Stratpharma Dominating
With 83% Ownership of the Shares, Smith & Nephew Plc (LON:SN.) Is Heavily Dominated by Institutional Owners
Smith+Nephew Announces New Evidence Supporting ALLEVYN LIFE Foam Dressing's Role in Pressure Injury Prevention
Smith+Nephew (NYSE:SNN, LSE:SN)), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group published in the
Sports Medicine Market Global Forecast 2024-2030, Featuring Key Players Zimmer Biomet, Medtronic, Smith & Nephew, Stryker, Novartis, Johnson & Johnson, Conmed and Surgalign Holdings.
Proxy Advisers Raise Concerns Over Smith & Nephew's Pay Hike Proposal
Proxy advisers cautioned Smith & Nephew (SN.L) shareholders regarding a new pay policy as part of a plan to reduce turnover of the company's executives. Institutional Shareholder Services urged shareh
JPMorgan's Top European Picks
JPMorgan analysts published their list of top European stocks.
Smith+Nephew Signs Exclusive Distribution Agreement to Provide Unique NAVBIT SPRINT Solution in Australia
Here's Why You Should Invest in Smith & Nephew Plc (SNN)
Smith & Nephew Says UK NICE Reaffirms Guidance on Pico Wound Dressing
Smith & Nephew (SNN) said Thursday that the UK National Institute for Health and Care Excellence has reaffirmed its guidance that the company's negative pressure wound dressing be considered an option
Smith+Nephew's PICO Single Use Negative Pressure Wound Therapy System Provides Better Clinical Outcomes Versus Standard of Care According to UK National Institute for Health and Care Excellence (NICE)
Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE) for its PICO
Investors Five-year Losses Continue as Smith & Nephew (LON:SN.) Dips a Further 5.6% This Week, Earnings Continue to Decline
Analysis
Price Target
No Data
